Innovita Biological Technology Co. Ltd. A (688253) — Cash Flow Quality Index
Innovita Biological Technology Co. Ltd. A (688253) has a Cash Flow Quality Index of 1.34x as of December 2025. Operating cash flow of CN¥193.13 Million exceeds net income of CN¥144.47 Million, indicating high earnings quality where cash backs reported profits. Also explore Innovita Biological Technology Co. Ltd. assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Innovita Biological Technology Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688253 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Innovita Biological Technology Co. Ltd. A. For live market cap and the full company financial profile, see 688253 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | CN¥193.13 Million | CN¥144.47 Million | ▲ +7.5% |
| 2024 | 1.24x | CN¥305.46 Million | CN¥245.69 Million | ▼ -16.8% |
| 2023 | 1.49x | CN¥259.85 Million | CN¥173.95 Million | ▲ +78.0% |
| 2022 | 0.84x | CN¥126.43 Million | CN¥150.68 Million | ▼ -5.1% |
| 2021 | 0.88x | CN¥106.27 Million | CN¥120.25 Million | ▼ -21.4% |
| 2020 | 1.12x | CN¥639.82 Million | CN¥569.00 Million | — |